Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 256

Results For "NDA"

4491 News Found

Emcure Pharmaceuticals to launch the750 mg injectable variant of ferric carboxymaltose
News | May 17, 2023

Emcure Pharmaceuticals to launch the750 mg injectable variant of ferric carboxymaltose

Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes


Hikal announces USFDA audit with zero observations
Drug Approval | May 16, 2023

Hikal announces USFDA audit with zero observations

This latest audit re-emphasizes Hikal's commitment towards maintaining the best in class quality, compliance and regulatory standards across our manufacturing sites


Kraiburg TPE is breaking the mold in Asia Pacific’s innovative medical devices
Medical Device | May 15, 2023

Kraiburg TPE is breaking the mold in Asia Pacific’s innovative medical devices

To enhance housing and enclosure design and performance for the Asia Pacific medical devices market, Kraiburg TPE offers the Thermoplast H HC/AP and HC/AD1/AP series


Nippon Express Italia receives IATA CEIV Pharma Certification for Its Facility near Milan Malpensa Airport
Supply Chain | May 13, 2023

Nippon Express Italia receives IATA CEIV Pharma Certification for Its Facility near Milan Malpensa Airport

Milan is also an important hub for the distribution of pharmaceuticals to the rest of Europe


Sanofi India to demerge healthcare businesses
News | May 12, 2023

Sanofi India to demerge healthcare businesses

This decision will accelerate growth for both its pharma & consumer healthcare businesses in India


USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’
Drug Approval | May 12, 2023

USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’

Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time


Takeda pledges support to HAE patients through its ‘Sunrise patient support program’
News | May 11, 2023

Takeda pledges support to HAE patients through its ‘Sunrise patient support program’

Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support


Boehringer Ingelheim begins clinical development for fibrotic diseases
News | May 10, 2023

Boehringer Ingelheim begins clinical development for fibrotic diseases

‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,


Zion Pharma inks agreement with Roche to develop and commercialize brain-penetrable compounds
News | May 10, 2023

Zion Pharma inks agreement with Roche to develop and commercialize brain-penetrable compounds

ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer


Dr Bharati Pravin Pawar launches Phase-III of Thalassemia Bal Sewa Yojana
Policy | May 09, 2023

Dr Bharati Pravin Pawar launches Phase-III of Thalassemia Bal Sewa Yojana

Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease